News:

This week IPhone 15 Pro winner is karn
You can be too a winner! Become the top poster of the week and win valuable prizes.  More details are You are not allowed to view links. Register or Login 

Main Menu

Pfizer drug effective in patients with rare lung cancer: study

Started by riky, September 28, 2014, 09:00:46 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

riky

Pfizer drug effective in patients with rare lung cancer: study

<p><a href="http://news.yahoo.com/pfizer-drug-effective-patients-rare-lung-cancer-study-105108293--finance.html"><img src="http://l2.yimg.com/bt/api/res/1.2/vf34AMAPT0d4jrycSYS_HQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9Njk7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2014-09-27T105108Z_1_LYNXNPEA8Q04U_RTROPTP_2_ASTRAZENECA-PFIZER.JPG" width="130" height="86" alt="The Pfizer logo is seen at their world headquarters in New York" align="left" title="The Pfizer logo is seen at their world headquarters in New York" border="0" /></a>By Bill Berkrot (Reuters) - Pfizer Inc's Xalkori, which treats lung cancer patients with a specific gene mutation, proved effective in shrinking tumors in those with an even rarer form of the disease, according to data presented at a medical meeting on Saturday. In the study of 50 non-small cell lung cancer patients with a rearrangement of the ROS1 gene, Xalkori treatment led to significant tumor shrinkage in 36 of them, or 72 percent, and halted tumor growth in an additional 9 patients, researchers reported. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login
You are not allowed to view links. Register or Login